We are a life science venture capital investor with experience in all therapeutic areas.

Our partners have unmatched drug development experience and have been responsible for the development, approval and commercialization of drugs having in excess of $50 billion in peak sales. We take a very active role in our portfolio companies and we work energetically with management to develop and grow their businesses.